AUROGRA

What is AUROGRA?

The drug AUROGRA is a modern pharmacological agent designed for the effective correction of vascular disorders and the restoration of the body's normal physiological response to sexual stimulation. This medicinal product belongs to the group of selective phosphodiesterase type 5 inhibitors, which are widely used in modern urology and andrology. The drug is available in the form of film-coated oral tablets, which ensures ease of use and optimal absorption rate of the active component in the gastrointestinal tract. The manufacturer of this product is the well-known pharmaceutical company Aurochem Laboratories, which has established itself as a reliable developer of high-quality generic drugs with strict quality control.

The main task of pharmacotherapy using AUROGRA is to restore lost or weakened erectile and vascular function by enhancing natural blood flow to the pelvic organs. The medical product is designed for adult men who experience reproductive system disorders of various degrees of severity and origin. Due to its high bioavailability, the active substance quickly reaches the plasma concentration necessary for a therapeutic effect. The drug complies with international safety standards, making it highly sought after by specialists involved in the regeneration of men's health.

The use of AUROGRA allows achieving a stable clinical result, minimizing psychological discomfort associated with vascular pathologies. The high efficacy of this pharmaceutical form is confirmed by multiple clinical trials and the practical experience of urologists. It should be understood that the product is not an artificial stimulant and acts exclusively in the presence of a natural source of neurogenic or hormonal signal. A properly selected course allows restoring a subjective sense of confidence and fully restoring the quality of the patient's personal life.

What is AUROGRA prescribed for?

The main area of application of AUROGRA covers the treatment of erectile dysfunction of various origins, including organic, psychogenic, and mixed forms of pathology. The drug helps men achieve and maintain a sufficient level of blood filling of the corpora cavernosa to perform a complete sexual intercourse. Due to its targeted effect on the pelvic vascular network, this agent effectively eliminates the consequences of stress, chronic fatigue, or age-related changes. Clinical observations show that regular or situational intake of tablets contributes to the normalization of blood circulation in critical areas.

In addition to eliminating primary disorders, AUROGRA is often prescribed as part of complex therapy to minimize psychological barriers caused by previous unsuccessful attempts or anxious expectation. The improvement of physiological indicators has a positive effect on the patient's general emotional state, reducing cortisol and tension levels. A secondary effect of use is considered to be the improvement of the general vascular tone of the hemodynamic system due to periodic dilation of arterioles. This makes the medication an important element in the restorative therapy of urinary and reproductive system disorders.

Another important aspect of the prescription is supporting the vascular system in coexisting systemic diseases that do not have direct contraindications to the use of PDE-5 inhibitors. For example, in mild forms of diabetes mellitus or atherosclerosis in the early stages, the product helps compensate for endothelial dysfunction. Timely prescription of the drug by a qualified doctor allows preventing the progression of vascular changes and preserving tissue functionality. It is important to remember that the choice of this product must be justified and based on a thoroughly established diagnosis.

Composition and active components of AUROGRA

The main active substance in AUROGRA is sildenafil citrate in a dosage corresponding to 100 mg of pure sildenafil in one tablet. The mechanism of action of this compound consists in the selective inhibition of the enzyme phosphodiesterase type 5 (PDE-5), which is responsible for the breakdown of cyclic guanosine monophosphate (cGMP). During sexual stimulation, local release of nitric oxide (NO) occurs, and the inhibition of PDE-5 allows cGMP levels to remain high. This leads to the relaxation of the smooth muscles of the corpora cavernosa and an increased flow of arterial blood.

The excipients included in the core matrix and film coating of AUROGRA ensure the stability of the chemical structure, the necessary rate of tablet disintegration, and protection of the stomach. These include microcrystalline cellulose, anhydrous calcium hydrogen phosphate, croscarmellose sodium, and magnesium stearate, which are standard safe pharmaceutical fillers. The coating contains hypromellose, titanium dioxide, and special dyes that give the tablet a recognizable appearance and facilitate its swallowing. All ingredients undergo multi-stage purification and are hypoallergenic for most patients.

The synergistic action of the active substance and the optimized form-giving base ensures a high rate of sildenafil release into the systemic circulation. Metabolism is carried out mainly in the liver with the participation of cytochrome P450 isoenzymes (CYP3A4 and CYP2C9). The main metabolite has properties similar to the parent compound, which prolongs the overall period of therapeutic activity of the drug. Elimination of metabolites occurs mainly with feces and to a lesser extent through the kidneys with urine, which should be taken into account when choosing a dose.

Dosage of AUROGRA

The recommended starting dose of AUROGRA for most adult men is 50 mg (half a tablet), taken as needed approximately one hour before anticipated sexual activity. Depending on individual efficacy and tolerability of the drug, the dose may be increased to the maximum allowable daily limit of 100 mg, which corresponds to one whole tablet. Exceeding the specified dosage within 24 hours is strictly prohibited due to the risk of systemic adverse reactions. Frequent or uncontrolled use of the product does not accelerate the onset of the result, but creates an excessive load on the cardiovascular system.

For elderly patients (over 65 years old), correction of the standard dosage is usually not required unless severe coexisting kidney or liver pathologies are present. However, doctors often recommend starting therapy with minimal doses (25–50 mg) to assess the individual reaction of the vascular system. In moderate renal or hepatic impairment, the rate of sildenafil clearance may slow down, requiring careful monitoring and a possible increase in the intervals between doses. The final dosage regimen should be established only by the treating physician after conducting appropriate tests.

The duration of AUROGRA use is determined individually and depends on the therapeutic goal — it can be either situational intake or inclusion in a long-term treatment scheme. The drug does not cause addiction or physical dependence during long-term use within the recommended doses. Changing the intake scheme or discontinuing the drug is carried out without the need for a gradual dose reduction. If the expected effect is not achieved after the first doses, you should not increase the dose on your own, but should consult a specialist.

How to take AUROGRA correctly?

AUROGRA should be taken orally, swallowing the tablet with a sufficient amount of clean still drinking water (about 150–200 ml). The optimal time of intake is 45–60 minutes before planned sexual activity, as it is during this period of time that the peak concentration of the active substance in the blood is reached. The tablet is recommended to be swallowed whole, without chewing or crushing, unless there is a need to divide the dose as directed by a doctor. The use of the drug is possible regardless of food intake, but some nuances of the diet should be taken into account.

Consuming a large amount of fatty food immediately before taking AUROGRA can slow down the absorption of sildenafil from the gastrointestinal tract and delay the onset of its action by 30–60 minutes. To achieve the fastest and most pronounced result, it is better to take the product on an empty stomach or after a light snack. In case of nausea or discomfort in the epigastrium when taken on an empty stomach, a small amount of carbohydrate food can be consumed. It is categorically not recommended to combine the intake with grapefruit or grapefruit juice, as this alters the metabolism of the medicine.

If the patient missed a planned situational intake, a double dose should not be taken to compensate. The drug is used only as needed, so the absence of intake does not negatively affect the further course of treatment. It should be remembered that AUROGRA manifests its effect only under the condition of natural sexual arousal, so the absence of an appropriate stimulus makes the tablet intake ineffective. After the completion of sexual intercourse, the erection naturally subsides due to physiological regulatory mechanisms.

Side effects of AUROGRA

The use of AUROGRA is well tolerated in most cases, however, like any active drug, it can cause side effects. The most common reactions (over 10% of cases) include headache and sudden flushing of blood to the face and upper body, accompanied by a feeling of warmth. Also often (from 1% to 10%) digestive disorders (dyspepsia, nausea), nasal congestion, dizziness, and temporary visual disturbances (change in color perception, increased sensitivity to light, blurred vision) are observed. These symptoms are usually mild or moderate in nature and pass on their own after the concentration of the substance in the blood decreases.

Uncommon and rare side effects (less than 1% of cases) include hypersensitivity reactions, including skin rashes, itching, eyelid swelling, as well as tinnitus or sudden hearing loss. From the cardiovascular system, tachycardia, increase or decrease in blood pressure are possible, and in exceptional cases — chest pain or arrhythmia. Very rarely, the development of priapism has been reported — a pathologically prolonged and painful erection that lasts more than 4 hours. This condition requires immediate medical intervention to prevent irreversible tissue damage.

If any severe adverse reactions occur, especially chest pain, sudden loss of vision, or severe allergic swelling, you should immediately stop taking AUROGRA and call an emergency medical service. Be sure to inform your doctor about all unusual manifestations that occurred during therapy to adjust the dose or select an alternative agent. It is important to remember the note regarding the individual reaction of the body, as the intensity of side effects depends on the patient's general health status.

Contraindications of AUROGRA

An absolute contraindication to the use of AUROGRA is the simultaneous use of nitric oxide donors, organic nitrates, or nitrites in any form, as sildenafil enhances their hypotensive effect. The drug is strictly prohibited for patients with severe heart failure, unstable angina, as well as those who have suffered a myocardial infarction or acute cerebrovascular accident (stroke) within the last 6 months. Also, the agent is not prescribed for severe hepatic impairment, arterial hypotension (pressure below 90/50 mm Hg), and hereditary degenerative diseases of the retina (for example, retinitis pigmentosa).

Relative contraindications require increased caution and a mandatory assessment of the benefit-risk ratio by a doctor. This group includes patients with anatomical deformation of the penis (Peyronie's disease, angular curvature), as well as individuals with a predisposition to priapism (sickle cell anemia, multiple myeloma, leukemia). Patients with exacerbation of gastric ulcer or bleeding disorders (hemophilia) should take AUROGRA under strict medical supervision. Persons with mild to moderate renal impairment require an individual dose selection.

Special patient groups include women and children: the drug AUROGRA is categorically contraindicated for women (including during pregnancy and lactation) and persons under 18 years of age. The use of the product in this category of patients has not been studied, and the safety of its use has not been confirmed. Elderly patients, in the absence of coexisting absolute contraindications, can use the product, but with careful monitoring of hemodynamic parameters. The warning about mandatory consultation with a doctor before starting intake is a fundamental safety rule.

Interaction of AUROGRA with other drugs and alcohol

The use of AUROGRA requires a detailed analysis of concomitant drug therapy due to the high risk of pharmacodynamic and pharmacokinetic interactions. Simultaneous use with alpha-blockers (drugs for the treatment of hypertension or prostate adenoma) can lead to symptomatic arterial hypotension in some susceptible patients, so a time interval must be observed between taking these medications. Potent inhibitors of the CYP3A4 isoenzyme (such as ketoconazole, itraconazole, erythromycin, ritonavir) significantly increase the level of sildenafil in blood plasma, which requires reducing the starting dose to 25 mg. Conversely, CYP3A4 inducers (rifampicin, St. John's wort preparations) can reduce the effectiveness of the medicine.

Simultaneous consumption of AUROGRA with alcoholic beverages is categorically not recommended, as ethanol independently depresses the central nervous system and can impair erectile function. In addition, the combination of alcohol with sildenafil significantly increases the risk of developing disorders of the cardiovascular system, such as a sharp drop in blood pressure, dizziness, fainting, and tachycardia. Regarding the effect on the ability to drive vehicles or work with complex mechanisms, patients should first assess their own reaction to the drug, as side effects such as dizziness and visual impairment are possible.

Where to buy AUROGRA in Ukraine

The product AUROGRA is available for purchase in pharmacies in Ukraine, as well as in specialized licensed online pharmaceutical platforms. Since this product belongs to the category of prescription medications, its purchase should be carried out after obtaining an appropriate prescription from the treating urologist or therapist. When choosing a seller, attention should be paid to the availability of quality certificates and compliance with the storage conditions of medicinal products. Ordering through online pharmacies allows receiving the product with prompt delivery by postal services to any region of the country while maintaining confidentiality.

Store AUROGRA in its original packaging at a temperature not exceeding 25 °C in a dry place, protected from light and out of reach of children. Do not use the drug after the expiration date indicated on the blister and cardboard box. Compliance with storage rules guarantees the preservation of the therapeutic properties of the active substance throughout its shelf life. Remember that the information about the description of the drug is provided for informational purposes, and before starting intake, a mandatory consultation with a doctor is required, taking into account the note about the individual reaction of the body.